Register Today to Reserve your Place!
With the aging of the population, the need for treatments of
ocular diseases and disorders has become more critical than ever. Increasingly
high incidences of age-related macular degeneration (AMD), glaucoma, diabetic
retinopathy and ocular inflammatory diseases demand better, more effective and
innovative treatments. If we are to maintain the quality of life for these
people, the preservation of vision is critical. This conference will address drug
targeting, novel and emerging treatments, along with novel and emerging
pathways that hold promise in treating these crippling conditions.
Hear Focused Sessions On:
250 First Avenue Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425E: email@example.com
biological therapeutic productsbiomarkers & diagnosticsbiopharma strategybioprocess & manufacturingchemistryclinical trials & translational medicinedrug & device safety
drug discovery & developmentdrug targetsgenomicshealthcareit & informaticstechnology & tools for life sciencetherapeutic indications
conferencesreportsbarnett educational servicesconsulting
publications & eNewsletters
executive teamtestimonialschi timelinemailing listcareers